000 | 01941 a2200517 4500 | ||
---|---|---|---|
005 | 20250516132840.0 | ||
264 | 0 | _c20131217 | |
008 | 201312s 0 0 eng d | ||
022 | _a1423-0313 | ||
024 | 7 |
_a10.1159/000346268 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVasconcelos Rios, Emiliano Ricardo | |
245 | 0 | 0 |
_aInvolvement of the nitric oxide/cyclic guanylate monophosphate pathway in the pilocarpine-induced seizure model in mice. _h[electronic resource] |
260 |
_bPharmacology _c2013 |
||
300 |
_a131-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmidines _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArginine _xpharmacology |
650 | 0 | 4 |
_aBenzylamines _xpharmacology |
650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGuanidines _xpharmacology |
650 | 0 | 4 |
_aGuanylate Cyclase _xantagonists & inhibitors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aOxadiazoles _xpharmacology |
650 | 0 | 4 | _aPilocarpine |
650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xantagonists & inhibitors |
650 | 0 | 4 |
_aSeizures _xchemically induced |
650 | 0 | 4 | _aSoluble Guanylyl Cyclase |
700 | 1 | _aMoura Rocha, Nayrton Flávio | |
700 | 1 | _aRodrigues Carvalho, Alyne Mara | |
700 | 1 | _aFreire Vasconcelos, Leonardo | |
700 | 1 | _aLeite Dias, Marília | |
700 | 1 | _ade Carvalho Lima, Camila Nayane | |
700 | 1 | _aSoares Lopes, Kamila | |
700 | 1 | _aCavalcante Melo, Francisca Helvira | |
700 | 1 | _ade França Fonteles, Marta Maria | |
773 | 0 |
_tPharmacology _gvol. 91 _gno. 3-4 _gp. 131-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000346268 _zAvailable from publisher's website |
999 |
_c22461478 _d22461478 |